首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1115860篇
  免费   77764篇
  国内免费   3183篇
耳鼻咽喉   14826篇
儿科学   34303篇
妇产科学   30371篇
基础医学   153892篇
口腔科学   28707篇
临床医学   97457篇
内科学   228081篇
皮肤病学   22067篇
神经病学   93580篇
特种医学   45722篇
外国民族医学   349篇
外科学   176033篇
综合类   21450篇
现状与发展   1篇
一般理论   426篇
预防医学   80130篇
眼科学   25190篇
药学   78252篇
  1篇
中国医学   2111篇
肿瘤学   63858篇
  2021年   10805篇
  2019年   11120篇
  2018年   14707篇
  2017年   11301篇
  2016年   12237篇
  2015年   14053篇
  2014年   20128篇
  2013年   29722篇
  2012年   41647篇
  2011年   43995篇
  2010年   25946篇
  2009年   24405篇
  2008年   40869篇
  2007年   43238篇
  2006年   42932篇
  2005年   42288篇
  2004年   40356篇
  2003年   38306篇
  2002年   37250篇
  2001年   43250篇
  2000年   43982篇
  1999年   38200篇
  1998年   12516篇
  1997年   11214篇
  1996年   10850篇
  1995年   10056篇
  1994年   9501篇
  1993年   8943篇
  1992年   29168篇
  1991年   27891篇
  1990年   27186篇
  1989年   26052篇
  1988年   24202篇
  1987年   23773篇
  1986年   22874篇
  1985年   21825篇
  1984年   16647篇
  1983年   14220篇
  1982年   9063篇
  1979年   15047篇
  1978年   10691篇
  1977年   9054篇
  1976年   8552篇
  1975年   9259篇
  1974年   11002篇
  1973年   10438篇
  1972年   9840篇
  1971年   9065篇
  1970年   8693篇
  1969年   8101篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Kinase alterations are increasingly recognised as oncogenic drivers in mesenchymal tumours. Infantile fibrosarcoma and the related renal tumour, congenital mesoblastic nephroma, were among the first solid tumours shown to harbour recurrent tyrosine kinase fusions, with the canonical ETV6::NTRK3 fusion identified more than 20 years ago. Although targeted testing has long been used in diagnosis, the advent of more robust sequencing techniques has driven the discovery of kinase alterations in an array of mesenchymal tumours. As our ability to identify these genetic alterations has improved, as has our recognition and understanding of the tumours that harbour these alterations. Specifically, this study will focus upon mesenchymal tumours harbouring NTRK or other kinase alterations, including tumours with an infantile fibrosarcoma-like appearance, spindle cell tumours resembling lipofibromatosis or peripheral nerve sheath tumours and those occurring in adults with a fibrosarcoma-like appearance. As publications describing the histology of these tumours increase so, too, do the variety kinase alterations reported, now including NTRK1/2/3, RET, MET, RAF1, BRAF, ALK, EGFR and ABL1 fusions or alterations. To date, these tumours appear locally aggressive and rarely metastatic, without a clear link between traditional features used in histological grading (e.g. mitotic activity, necrosis) and outcome. However, most of these tumours are amenable to new targeted therapies, making their recognition of both diagnostic and therapeutic import. The goal of this study is to review the clinicopathological features of tumours with NTRK and other tyrosine kinase alterations, discuss the most common differential diagnoses and provide recommendations for molecular confirmation with associated treatment implications.  相似文献   
2.
European Surgery - Large skin defects caused by trauma (e.g., burns) or due to other reasons (e.g., tumor-related skin resections) require sufficient skin replacement. The constant improvement of...  相似文献   
3.
Die Anaesthesiologie - Phantomschmerzen haben eine hohe Prävalenz nach Majoramputationen und sind mit einer zusätzlichen Einschränkung der Lebensqualität verbunden....  相似文献   
4.
5.
6.
7.
8.
9.
10.
Gestational trophoblastic neoplasia (GTN) patients are treated according to the eight-variable International Federation of Gynaecology and Obstetrics (FIGO) scoring system, that aims to predict first-line single-agent chemotherapy resistance. FIGO is imperfect with one-third of low-risk patients developing disease resistance to first-line single-agent chemotherapy. We aimed to generate simplified models that improve upon FIGO. Logistic regression (LR) and multilayer perceptron (MLP) modelling (n = 4191) generated six models (M1-6). M1, all eight FIGO variables (scored data); M2, all eight FIGO variables (scored and raw data); M3, nonimaging variables (scored data); M4, nonimaging variables (scored and raw data); M5, imaging variables (scored data); and M6, pretreatment hCG (raw data) + imaging variables (scored data). Performance was compared to FIGO using true and false positive rates, positive and negative predictive values, diagnostic odds ratio, receiver operating characteristic (ROC) curves, Bland-Altman calibration plots, decision curve analysis and contingency tables. M1-6 were calibrated and outperformed FIGO on true positive rate and positive predictive value. Using LR and MLP, M1, M2 and M4 generated small improvements to the ROC curve and decision curve analysis. M3, M5 and M6 matched FIGO or performed less well. Compared to FIGO, most (excluding LR M4 and MLP M5) had significant discordance in patient classification (McNemar's test P < .05); 55-112 undertreated, 46-206 overtreated. Statistical modelling yielded only small gains over FIGO performance, arising through recategorisation of treatment-resistant patients, with a significant proportion of under/overtreatment as the available data have been used a priori to allocate primary chemotherapy. Streamlining FIGO should now be the focus.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号